Skip to content

Drug interactions

Eplerenone + Lapatinib

Severity: Moderate

Eplerenone and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib inhibits CYP3A4 and may raise eplerenone exposure, increasing the risk of hyperkalemia. The magnitude is likely modest, but it matters in patients with renal impairment.

What this interaction means in plain words

Eplerenone and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eplerenone belongs to Cardiovascular; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated eplerenone metabolism.

What to do

Monitor serum potassium and renal function after starting lapatinib. Reduce the eplerenone dose if potassium rises.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eplerenone and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eplerenone with Lapatinib?

MediHelp rates the interaction as moderate. Eplerenone and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lapatinib inhibits CYP3A4 and may raise eplerenone exposure, increasing the risk of hyperkalemia. The magnitude is likely modest, but it matters in patients with renal impairment.

How serious is the interaction between Eplerenone and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function after starting lapatinib. Reduce the eplerenone dose if potassium rises.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in